corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 12059

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

McKee S.
ABPI Code set for further revision
Pharma Times 2007 Nov 20
http://www.pharmatimes.com/uknews/article.aspx?id=12270


Full text:

The Association of the British Pharmaceutical Industry’s Code of Practice is being modified yet again, this time to ensure that it mirrors new guidelines recently issued by the European Federation of Pharmaceutical Industries and Associations.

The ABPI’s Code of Practice was set up in 1958 to provide pharmaceutical companies with a regulatory framework to follow in their dealings and interactions with doctors and other healthcare professionals. Those falling foul of the Code could face suspension from the Association or a public naming and shaming via adverts in the pharmaceutical and medical press, with punishments designed to have maximum impact on the company while boosting the public’s perception of the industry.

Following the introduction of a new, tougher version in January last year, the Code will now be revised again to cover certain aspects of pharmaceutical companies’ relationships with patient organisations, as laid out in the EFPIA’s code.

More transparency
These changes, which need to be implemented by July 1 next year, are clearly geared towards booting the level of transparency of relationships between the industry and patient groups, and include a new requirement on firms to include a short description of the nature of the support they provide, as well as the declaration of financial backing, indirect or non-financial support, the ABPI said.

Furthermore, the Code may be tweaked in other areas too. As Nigel Brooksby, President of the ABPI, explained: “As well as taking on board the comparatively small number of changes that the new European patient code makes necessary, we shall be looking at including any suggested alterations identified during the life of the current code.”

Unfortunately, a spokesperson for the ABPI was not able to give any further details on what these other changes may be.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909